Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimal Therapy for Postoperative Recurrence: Does Salvage Radiation Work for Locoregional Recurrence?
Taniguchi Y, Shigenobu T, Hayashi A, Hirahara A, Ito K, Shinohara H, Shiba A, Higashi Y, Tabuchi Y, Suzuki T, Aga M, Hamakawa Y, Miyazaki K, Sato M, Misumi Y, Agemi Y, Nakamura Y, Shimokawa T, Odagiri K, Yoshizu A, Okamoto H. Taniguchi Y, et al. Among authors: misumi y. Anticancer Res. 2024 Dec;44(12):5541-5549. doi: 10.21873/anticanres.17380. Anticancer Res. 2024. PMID: 39626937
Efficacy of PD-1 Inhibitors in Older Non-small Cell Lung Cancer Patients.
Nakamura Y, Miyazaki K, Aiko N, Misumi Y, Agemi Y, Taniguchi Y, Ishi M, Shimokawa T, Okamoto H, Yamanaka T. Nakamura Y, et al. Among authors: misumi y. Anticancer Res. 2020 Feb;40(2):923-928. doi: 10.21873/anticanres.14025. Anticancer Res. 2020. PMID: 32014936
Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC.
Hamakawa Y, Agemi Y, Shiba A, Ikeda T, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Nakamura Y, Shimokawa T, Saigusa Y, Kobayashi N, Okamoto H, Kaneko T. Hamakawa Y, et al. Among authors: misumi y. Cancer Med. 2023 Sep;12(17):17788-17797. doi: 10.1002/cam4.6405. Epub 2023 Aug 7. Cancer Med. 2023. PMID: 37548381 Free PMC article.
Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
Aiko N, Shimokawa T, Miyazaki K, Misumi Y, Agemi Y, Ishii M, Nakamura Y, Yamanaka T, Okamoto H. Aiko N, et al. Among authors: misumi y. BMC Cancer. 2018 Oct 22;18(1):1012. doi: 10.1186/s12885-018-4911-7. BMC Cancer. 2018. PMID: 30348116 Free PMC article.
390 results